Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Retained Earnings (2022 - 2026)

HeartSciences (HSCS) has disclosed Retained Earnings for 4 consecutive years, with -$80.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 12.59% year-over-year to -$80.5 million, compared with a TTM value of -$80.5 million through Oct 2025, down 12.59%, and an annual FY2025 reading of -$76.1 million, down 13.01% over the prior year.
  • Retained Earnings was -$80.5 million for Q4 2025 at HeartSciences, down from -$78.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$54.4 million in Q2 2022 and bottomed at -$80.5 million in Q4 2025.
  • Average Retained Earnings over 4 years is -$66.4 million, with a median of -$65.5 million recorded in 2024.
  • The sharpest move saw Retained Earnings dropped 10.59% in 2023, then dropped 13.01% in 2025.
  • Year by year, Retained Earnings stood at -$57.8 million in 2022, then fell by 10.59% to -$63.9 million in 2023, then dropped by 11.89% to -$71.5 million in 2024, then dropped by 12.59% to -$80.5 million in 2025.
  • Business Quant data shows Retained Earnings for HSCS at -$80.5 million in Q4 2025, -$78.2 million in Q3 2025, and -$76.1 million in Q2 2025.